<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250409065266N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-26</date_registration>
      <primary_sponsor>Allameh Tabatabae University of Tehran</primary_sponsor>
      <public_title>Effects of Reactive Exercises on Muscle Strength and Perceived Ankle Instability in Soccer Players</public_title>
      <acronym></acronym>
      <scientific_title>Effects of Reactive Neuromuscular Training on Muscle Strength and Perceived Ankle Instability in Soccer Players with Chronic Ankle Instability</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-02-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/82810</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: We very simply wrote two words, interference and non-interference, on paper (the number of these sheets was equal to the number of subjects) and dropped them into a ball. We asked the subject to pick one of these papers. After reading the paper and registering the individual in the selected group, the paper was placed back into the ball.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic ankle instability in football players.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants performed an 8-week reactive neuromuscular training (RNT) program, consisting of three sessions per week, each lasting 30–60 minutes. The program included eight exercises targeting lower-limb neuromuscular control, balance, strength, and dynamic stability. Training volume was progressively increased throughout the intervention period, with prescribed sets and repetitions adjusted weekly. Rest intervals were 2 minutes during weeks 1–4, 1.5 minutes during weeks 5–7, and 1 minute during week 8. Intervention 2: Control group: Participants did not receive any specific intervention during the 8-week study period.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The data of the participants can be shared without mentioning their name. These data are related to the main and secondary consequence during the research.

When:
Starting the course of 6 months after printing the results of the article

To whom:
All people in universities and industry can do this for a specified period of time.

Conditions:
Applicants can evaluate and analyze the analysis data from the two devices used in this study with permission from the researcher.

Where to obtain:
Directly with the researcher herself by electronic address: mojtaba.faraji90@gmail.com or Mobile Number 00989194102304

How to obtain:
The applicant receives the information for up to one month after submitting the application.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mojtaba Faraji</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Allameh Tabatabaei University, Faculty of Physical Education and Sport Sciences, opposite Olympic Hotel, West Boulevard of Azadi Stadium, Chogan Boulevard, Hakim West Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1485643449</zip>
        <telephone>+98 21 4839 4172</telephone>
        <email>mojtaba.faraji90@gmail.com</email>
        <affiliation>Allameh Tabatabae University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Hashem Piri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Allameh Tabatabaei University, Faculty of Physical Education and Sport Sciences, opposite Olympic Hotel, West Boulevard of Azadi Stadium, Chogan Boulevard, Hakim West Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1485643449</zip>
        <telephone>+98 21 4839 4172</telephone>
        <email>Hpiry63@gmail.com</email>
        <affiliation>Allameh Tabatabae University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>No history of knee or hip joint injuries in the past six months.
At least one episode of recurrent ankle sprain that caused swelling, pain, and reduced ankle function.
At least on year has passed since the first ankle sprain occurred.
Age range between 16 and 20 years.
At least 3 years of experience in playing football.</inclusion_criteria>
      <agemin>16 years</agemin>
      <agemax>20 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>History of bilateral ankle sprains
Failure to adhere to the training program (missing three non-consecutive sessions or two consecutive sessions)
Sustaining an injury during the intervention period</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M24.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Disorder of ligament</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants performed an 8-week reactive neuromuscular training (RNT) program, consisting of three sessions per week, each lasting 30–60 minutes. The program included eight exercises targeting lower-limb neuromuscular control, balance, strength, and dynamic stability. Training volume was progressively increased throughout the intervention period, with prescribed sets and repetitions adjusted weekly. Rest intervals were 2 minutes during weeks 1–4, 1.5 minutes during weeks 5–7, and 1 minute during week 8.</i_keyword>
      <i_keyword>Control group: Participants did not receive any specific intervention during the 8-week study period.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Change in peroneal muscle strength from pre-intervention to post-intervention following 8 weeks of reactive neuromuscular training in soccer players with chronic ankle instability, measured using a hand-held dynamometer. Timepoint: Peroneal muscle strength will be measured at baseline, before the intervention, and immediately after completion of the eight-week reactive neuromuscular training program. Method of measurement: Hand-held dynamometer for measuring peroneal muscle strength.</prim_outcome>
      <prim_outcome>Change in perceived ankle instability score from pre-intervention to post-intervention following 8 weeks of reactive neuromuscular training in soccer players with chronic ankle instability, measured using a validated ankle instability questionnaire. Timepoint: Perceived ankle instability will be assessed at baseline, before the intervention, and immediately after completion of the eight-week reactive neuromuscular training program. Method of measurement: The questionnaire used in the study to assess perceived ankle instability, with scores recorded at pre-intervention and post-intervention assessments.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Change in ankle pain intensity during daily activities from baseline to immediately after completion of the eight-week intervention. Timepoint: Ankle pain intensity during daily activities will be assessed at baseline, before the intervention, and immediately after completion of the eight-week intervention. Method of measurement: A 100-mm Visual Analogue Scale, scored from 0 to 100, with 0 indicating no pain and 100 indicating the worst imaginable pain.</sec_outcome>
      <sec_outcome>Change in foot and ankle function during activities of daily living and sports activities from baseline to immediately after completion of the eight-week intervention. Timepoint: Foot and ankle function during activities of daily living and sports activities will be assessed at baseline, before the intervention, and immediately after completion of the eight-week intervention. Method of measurement: The Foot and Ankle Ability Measure, a 29-item questionnaire comprising the Activities of Daily Living subscale (21 items) and the Sports subscale (8 items). Scores are expressed as percentages, with higher scores indicating better function.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mojtaba Faraji</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-05-29</approval_date>
        <contact_name>Allameh Tabatabaei University Ethics Committee</contact_name>
        <contact_address>No 2, Babae alley, Mollasalehi alley, Pahlavani Street, Shahid Arab street, Ghazvin street Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
